
Bayer Submits EU Application for Aflibercept 8 mg to Treat Retinal Vein Occlusion
Bayer Submits EU Application for Aflibercept 8 mg to Treat Retinal Vein Occlusion Bayer Submits EU AG has officially submitted an application to the European Medicines Agency (EMA) seeking approval for aflibercept 8 mg (114.3 mg/ml solution for injection) for…